Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On December 30, 2025, the stockholders of Apimeds Pharmaceuticals US, Inc., a Delaware corporation (the “Company”), acting by written consent, removed Erik Emerson from the Company’s board of directors, effective as of such date. The removal was effected by the affirmative vote of stockholders holding a majority of the outstanding shares of common stock of the Company’s voting power entitled to vote generally in the election of directors, and was taken with or without cause, in accordance with the Company’s organizational documents and applicable law.